National Research Council, Institute of Biostructure and Bioimaging Catania, Italy., National Research Council, Institute of Biostructure and Bioimaging Catania, Italy ; PhD Program in Neuropharmacology, University of Catania Catania, Italy., National Research Council, Institute of Biostructure and Bioimaging Catania, Italy ; Department of Clinical and Molecular Biomedicine, University of Catania Catania, Italy., Department of Drug Sciences, University of Catania Catania, Italy ; IRCCS Associazione Oasi Maria S.S., Institute for Research on Mental Retardation and Brain Aging Troina, Italy., Department of Molecular Pathology, Neuropharmacology Unit, IRCCS Neuromed Pozzilli, Italy., Department of Drug Sciences, University of Catania Catania, Italy., NEUROFARBA, University of Florence Florence, Italy., Department of Molecular Pathology, Neuropharmacology Unit, IRCCS Neuromed Pozzilli, Italy ; Department of Human Physiology and Pharmacology, University "La Sapienza" Rome, Italy., National Research Council, Institute of Biostructure and Bioimaging Catania, Italy ; Department of Drug Sciences, University of Catania Catania, Italy.,
References: Beguinot, F., Kahn, C.R., Moses, A.C., Smith, R.J., Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells (1985) J. Biol. Chem, 260, pp. 15892-1589
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., Vigneri, R., Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease (2009) Endocr. Rev, 30, pp. 586-623
Bilan, P.J., Mitsumoto, Y., Maher, F., Simpson, I.A., Klip, A., Detection of the GLUT3 facilitative glucose transporter in rat L6 muscle cells: Regulation by cellular differentiation, insulin and insulin-like growth factor-I (1992) Biochem. Biophys. Res. Commun, 186, pp. 1129-1137
Bilic, E., Rudan, I., Kusec, V., Zurak, N., Delimar, D., Zagar, M., Comparison of of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls (2006) Eur. J. Neurol, 13, pp. 1340-1345
Bondy, C.A., Cheng, C.M., Signaling by insulin growht factor-1 in brain (2004) Eur. J. Pharmacol, 490, pp. 25-31
Caselli, R.J., Chen, K., Lee, W., Alexander, G.E., Reiman, E.M., Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment (2008) Arch. Neurol, 65, pp. 1231-1236
Chalifour, R.J., McLaughlin, R.W., Lavoie, L., Morissette, C., Tremblay, N., Boulé, M., Stereoselective interactions of peptide inhibitors with the beta-amyloid peptide (2003) J. Biol. Chem, 278, pp. 34874-34881
Chishti, M.A., Yang, D.S., Janus, C., Phinney, A.L., Horne, P., Pearson, J., Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 (2001) J. Biol. Chem, 276, pp. 21562-21570
Cirrito, J.R., May, P.C., O'Dell, M.A., Taylor, J.W., Parsadanian, M., Cramer, J.W., In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life (2003) J. Neurosci, 23, pp. 8844-8853
Cirrito, J.R., Yamada, K.A., Finn, M.B., Sloviter, R.S., Bales, K.R., May, P.C., Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo (2005) Neuron, 48, pp. 913-922
de la Monte, S.M., Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease (2012) Front. Biosci. (Elite. Ed), 4, pp. 1582-1605
De smet, F., Christoupouls, A., Carmeliet, P., Allostering targeting of receptor tyrosine kinases (2014) Nat. Biotechnol, 32, pp. 1113-1120
Giuffrida, M.L., Caraci, F., Pignataro, B., Cataldo, S., De Bona, P., Bruno, V., Beta-amyloid monomers are neuroprotective (2009) J. Neurosci, 29, pp. 10582-10587
Hanna, A., Iremonger, K., Das, P., Dickson, D., Golde, T., Janus, C., Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis (2012) Alzheimers Res. Ther, 4, pp. 21-31
Higgins, L.S., Murphy, G.M., Jr., Forno, L.S., Catalano, R., Cordell, B., P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain (1996) Am. J. Pathol, 149, pp. 585-596
Hohmeier, H.E., Mulder, H., Chen, G., Henkel-Rieger, R., Prentki, M., Newgard, C.B., Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion (2000) Diabetes, 49, pp. 424-430
Ivanov, A.I., Malkov, A.E., Waseem, T., Mukhtarov, M., Buldakova, S., Gubkina, O., Glycolysis and oxidative phosphorylation in neurons and astrocytes during network activity in hippocampal slices (2014) J. Cereb. Blood Flow Metab, 34, pp. 397-407
Jayaraman, A., Pike, C.J., Alzheimer's disease and type 2 diabetes: Multiple mechanisms contribute to interactions (2014) Curr. Diab. Rep, 14, p. 476
Karran, E., Hardy, J., A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease (2014) Ann. Neurol, 76, pp. 185-205
Kelleher, R.J., III, Bear, M.F., The autistic neurons: Troubled translation? (2008) Cell, 135, pp. 401-406
Kessler, J., Herholz, K., Grond, M., Heiss, W.D., Impaired metabolic activation in Alzheimer's disease: A PET study during continuous visual recognition (1991) Neuropsychologia, 29, pp. 229-243
Lucignani, G., Namba, H., Nehlig, A., Porrino, L.J., Kennedy, C., Sokoloff, L., Effects of insulin on local cerebral glucose utilization in the rat (1987) J. Cereb. Blood Flow Metab, 7, pp. 309-314
McEwen, B.S., Reagan, L.P., Glucose transporter expression in the central nervous system: Relationship to synaptic function (2004) Eur. J. Pharmacol, 490, pp. 13-24
Mosconi, L., Sorbi, S., de Leon, M.J., Li, Y., Nacmias, B., Myoung, P.S., Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease (2006) J. Nucl. Med, 47, pp. 1778-1786
Nag, S., Sarkar, B., Bandyopadhyay, A., Sahoo, B., Sreenivasan, V.K., Kombrabail, M., Nature of the amyloid-beta monomer and the monomer-oligomer equilibrium (2011) J. Biol. Chem, 286, pp. 13827-13833
Nutu, M., Bourgeois, P., Zetterberg, H., Portelius, E., Andreasson, U., Parent, S., Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases (2013) Neuromolecular Med, 15, pp. 169-179
Oksbjerg, N., Gondret, F., Vestergaard, M., Basic principles of muscle development and growth in meat-producing mammals as affected by the insulin-like growth factor (IGF) system (2004) Domest. Anim. Endocrinol, 27, pp. 219-240
Pandini, G., Frasca, F., Mineo, R., Sciacca, L., Vigneri, R., Belfiore, A., Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved (2002) J. Biol. Chem, 277, pp. 39684-39695
Petersen, R.C., Stevens, J.C., Ganguli, M., Tangalos, E.G., Cummings, J.L., DeKosky, S.T., Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology (2001) Neurology, 56, pp. 1133-1142
Pike, C.J., Overman, M.J., Cotman, C.W., Amino-terminal deletions enhance aggregation of beta-amyloid peptidesin vitro (1995) J. Biol. Chem, 270, pp. 23895-23898
Piriz, J., Muller, A., Trejo, J.L., Torres-Aleman, I., IGF-I and the aging mammalian brain (2011) Exp. Gerontol, 46, pp. 96-99
Reed, M.N., Hofmeister, J.J., Jungbauer, L., Welzel, A.T., Yu, C., Sherman, M.A., Cognitive effects of cell-derived and synthetically derived Aβ oligomers (2011) Neurobiol. Aging, 32, pp. 1784-1794
Reiman, E.M., Chen, K., Alexander, G.E., Caselli, R.J., Bandy, D., Osborne, D., Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia (2004) Proc. Natl. Acad. Sci. U.S.A, 101, pp. 284-289
Reiman, E.M., Uecker, A., Gonzalez-Lima, F., Minear, D., Chen, K., Callaway, N.L., Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography (2000) Neuroreport, 11, pp. 987-991
Selkoe, D.J., Resolving controversies on the path to Alzheimer's therapeutichs (2011) Nat. Med, 17, pp. 1060-1065
Shivers, B.D., Hilbich, C., Multhaup, G., Salbaum, M., Beyreuther, K., Seeburg, P.H., Alzheimer's disease amyloidogenic glycoprotein: Expression pattern in rat brain suggests a role in cell contact (1998) EMBO J, 7, pp. 1365-1370
Simpson, I.A., Dwyer, D., Malide, D., Moley, K.H., Travis, A., Vannucci, S.J., The facilitative glucose transporter GLUT3: 20 years of distinction (2008) Am. J. Physiol. Endocrinol. Metab, 295, pp. E242-E245
Stranahan, A.M., Mattson, M.P., Metabolic reserve as a determinant of cognitive aging (2012) J. Alzheimers. Dis, 30, pp. S5-S13
Taha, C., Tsakiridis, T., McCall, A., Klip, A., Glucose transporter expression in L6 muscle cells: Regulation through insulin- and stress-activated pathways (1997) Am. J. Physiol, 273, pp. E68-E76
Talbot, K., Wang, H.Y., Kazi, H., Han, L.Y., Bakshi, K.P., Stucky, A., Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline (2012) J. Clin. Invest, 122, pp. 1316-1338
Tampellini, D., Rahman, N., Lin, M.T., Capetillo-Zarate, E., Gouras, G.K., Impaired β-amyloid secretion in Alzheimer's disease pathogenesis (2011) J. Neurosci, 26, pp. 15384-15390
Tjemberg, L.O., Arrest of beta-amyloid fibril formation by a pentapeptide ligand (1996) J. Biol. Chem, 271, pp. 8545-8548
Toye, A.A., Lippiat, J.D., Proks, P., Shimomura, K., Bentley, L., Hugill, A., A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice (2005) Diabetologia, 48, pp. 675-686
Uemura, E., Greenlee, H.W., Insulin regulates glucose uptake by promoting traslocation of glucose transporter GLUT3 (2006) Exp. Neurol, 198, pp. 48-53
Van Schravendijk, C.F., Heylen, L., Van den Brande, J.L., Pipeleers, D.G., Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells (1990) Diabetologia, 33, pp. 649-653
Yang, Q., Yamagata, K., Fukui, K., Cao, Y., Nammo, T., Iwahashi, H., Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells (2002) Diabetes, 51, pp. 785-792
Zhang, B., Tang, X.C., Zhang, H.Y., Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models (2013) J. Neurosci. Res, 91, pp. 717-725
Zhao, W.Q., De Felice, F.G., Fernandez, S., Chen, H., Lambert, M.P., Quon, M.J., Amyloid beta oligomers induce impairment of neuronal insulin receptors (2008) FASEB J, 22, pp. 246-260
Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons